Spravato®Verificado en registro oficialModelo de mercado privado
Klinikum Nürnberg — Klinik für Psychiatrie und Psychotherapie (Campus Nord)
Nürnberg, Alemania
Tratamiento y acceso
- Tratamientos ofrecidosesketamine (Spravato)
- Vía de accesoCubierto por un programa nacional
- Coste y cobertura (estado en el registro)Covered by GKV for on-label TRD; see country guide
- ReembolsoGKV — hospital financing for day-clinic/inpatient induction; outpatient maintenance via PIA Campus Nord for up to 6 months Cómo funciona el reembolso en Europa →
- Teléfono+49 911 398-9074
- Sitio webhttps://www.klinikum-nuernberg.de/behandlung/seelische-gesundheit/
Sobre este proveedor
Klinikum Nürnberg is one of Europe's largest municipal hospitals and a teaching hospital of Paracelsus Medical University. Its Department of Psychiatry and Psychotherapy at Campus Nord publishes a referrer newsletter on its own domain that sets out a formal Spravato pathway: intranasal esketamine delivered in a day-clinic or inpatient setting over three to six weeks, followed where successful by outpatient maintenance for up to six months through the hospital's psychiatric institute outpatient clinic (PIA). A dedicated referral phone line and email are published.
Verificación
- Licencia / registroRegistro público de ensayos (ClinicalTrials.gov / EU CTIS)
- Fuentehttps://www.klinikum-nuernberg.de/fileadmin/user_upload/Flyer_Dokumente_Verwaltung/Unternehmenskommunikation_UK/Newsletter_Kliniken/Newsletter_Psychiatrie_Psychotherapie_2023-1.pdf
- Última verificación